In February we saw 2 sizeable crossings.
Mathew Consulting reduced by 9 million shares (2 Feb)
Norman Zilman reduced by 1.5 million shares (2 Feb)
No real additions to top 20 except for Cogent Nominees with 2.2 million shares.
So I conclude that there is no major player taking a sizeable stake right now and the crossings were arranged most likely with a few brokers for their high net worth clients.
Add to My Watchlist
What is My Watchlist?